vimarsana.com

Page 19 - கூட்டணி க்கு பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunisation: WHO grants emergency validation for Pfizer vaccine: What this means for developing nations

Updated Jan 01, 2021 | 11:30 IST The latest development is another step in the WHO s charge to ensure safe and equitable access to diagnostic and treatment resources to all countries regardless of their socio-economic profiles. The Pfizer-BioNTech vaccine being administered to a 67-year old man at Jackson Memorial Hospital in Miami, Florida.  |  Photo Credit: AP Key Highlights Although vaccine developers are working tirelessly to ramp up manufacturing and distribution of vaccines, there is a consensus that the early months of the global immunisation rollout will see demand far outstrip supply COVAX has since announced that it has supply agreements in place with several vaccine manufacturers to provide almost 2 billion doses that it expects to deliver within the year

Bill Gates says current breakthroughs will make 2021 better than 2020

This has been a devastating year. More than 1.6 million people have died in the COVID-19 pandemic, with more than 75 million cases and tens of trillions of dollars in economic damages. Millions of people are out of work and struggling to pay their bills, and more than a billion children are missing out on crucial time in school. In the U.S., this year also saw the horrifying killings of George Floyd and Breonna Taylor, ruinous wildfires, and a presidential election unlike any other in modern times. But there is good news coming in 2021. I spent most of my time this year working with colleagues at the foundation and around the world on ways to test for, treat, and prevent COVID-19. When I think back on the pace of scientific advances in 2020, I am stunned. Humans have never made more progress on any disease in a year than the world did on COVID-19 this year. Under normal circumstances, creating a vaccine can take 10 years. This time, multiple vaccines were created in less than one y

We Don t Know Why COVID-19 Cases, Deaths Are Not High In Africa -- Bill Gates

We Don t Know Why COVID-19 Cases, Deaths Are Not High In Africa Bill Gates According to Gates, it is possible that the figures provided are not real due to the gaps in health care systems in Africa. by SaharaReporters, New York Dec 27, 2020 Co-founder of Microsoft Foundation, Bill Gates, has said he does not know why COVID-19 cases and deaths in Africa are low as against the figures obtainable in developed countries. According to Gates, it is possible that the figures provided are not real due to the gaps in health care systems in Africa. Bill Gates Harry Graphic He said, It is also possible though I hope this is not the case that the true numbers are higher than they look because gaps in poor countries’ health care systems are making it hard to monitor the disease accurately.

Bill Gates Just Revealed 12 Inspiring Reasons to Be Very Hopeful in 2021

 Getty Images Back in 2015, Bill Gates largely predicted the pandemic. As a result, I ve followed his subsequent pronouncements and predictions with special care. No, Gates isn t a perfect person, and he s not the single source of truth. But after he s dedicated so much time and money to combating the pandemic, I was eager to read his latest blog post, in which he revealed the breakthroughs that he thinks  will make 2021 better than 2020. You can decide for yourself, but I think he does a good job of wrapping up positive developments, and delivering them in a way that s hopeful without being Pollyanna-ish.

UNICEF launches the COVID-19 vaccine market dashboard - World

UNICEF launches the COVID-19 vaccine market dashboard Format NEW YORK / KATHMANDU, 21 December 2020 – As the designated COVAX procurement coordinator and procurement agent, UNICEF has launched the COVID-19 Vaccine Market Dashboard – an interactive tool for countries, partners and industry to follow the developments of the rapidly evolving COVID-19 vaccine market and the efforts of the COVAX Facility to ensure fair and equitable access for every country in the world. In this first release, the dashboard provides a regularly updated overview of the global research and development pipeline, the projected production capacity, publicly announced bilateral and multilateral supply agreements, as well as reported price points.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.